The effect of 2-butyne-1, 4-diol on silver electrodeposition process from 5, 5-dimethyl hydantoin solutions was investigated by means of cyclic voltammetric measurement, scanning electron microscopy (SEM) and X-ray di...The effect of 2-butyne-1, 4-diol on silver electrodeposition process from 5, 5-dimethyl hydantoin solutions was investigated by means of cyclic voltammetric measurement, scanning electron microscopy (SEM) and X-ray diffraction (XRD). Cyclic voltammetric studies indicate that the reduction process of silver electrodeposition is influenced by adding 2-butyne-1, 4-diol. Owing to its adsorption on the electrode surface, 2-butyne-1, 4-diol moderately hinders the mass transfer of the silver complexed ions from the bulk solution to the outer limit of the electrode double layer and affects the electrocrystallization step. Scanning electron microscopy analysis reveals that the presence of 2-butyne-1, 4-diol in the electrolyte is beneficial and the silver deposits obtained are smoother, more compact and more leveled. X-ray diffraction analysis of the silver deposits obtained at 0.5 g·L-1 2-butyne-1, 4-diol indicated that the (110) plane is the most preferred plane and is not affected by the presence of 2-butyne-1, 4-diol in the electrolyte.展开更多
目的研究厚朴抗炎有效成分(E)-5-allyl-3'-(prop-1-enyl)biphenyl-2,4'-diol(HK-1)在人、大鼠、比格犬、猴和小鼠的肝微粒体中的代谢稳定性,确定HK-1在大鼠肝微粒体中代谢表型。方法将HK-1在5个种属肝微粒体中孵育,采用UPLC-MS...目的研究厚朴抗炎有效成分(E)-5-allyl-3'-(prop-1-enyl)biphenyl-2,4'-diol(HK-1)在人、大鼠、比格犬、猴和小鼠的肝微粒体中的代谢稳定性,确定HK-1在大鼠肝微粒体中代谢表型。方法将HK-1在5个种属肝微粒体中孵育,采用UPLC-MS/MS检测方法,通过测定HK-1的剩余浓度,考察它们的代谢稳定性并外推其体内代谢清除率。化学抑制剂法鉴定在大鼠肝微粒体中HK-1的代谢表型。结果 HK-1在人、大鼠、比格犬、猴和小鼠5个种属肝微粒体中半衰期(t_(1/2))分别为9.04、7.36、2.17、4.94、18.09 min;肝微粒体中固有清除率CL_(int)分别为153.40、188.20、639.02、280.60、76.60 m L/(min·mg蛋白);体内固有清除率CL'_(int)分别为151.87、338.76、949.21、416.69、301.61 m L/(min·kg)。在大鼠肝微粒体中HK-1主要被细胞色素CYP2E1、CYP2C、CYP1A2催化代谢。结论HK-1在肝微粒体中由多种酶代谢且代谢很快,其中人肝微粒体和大鼠肝微粒体中半衰期和固有清除率相似,可将大鼠肝微粒体预估人肝微粒体不良反应的风险。展开更多
Male pattern baldness or androgenic alopecia is a great problem for many individuals’ especially young people. A100 is composed of two active ingredients, a pollen extract and pentane-1,5-diol. The pollen extract pro...Male pattern baldness or androgenic alopecia is a great problem for many individuals’ especially young people. A100 is composed of two active ingredients, a pollen extract and pentane-1,5-diol. The pollen extract provides a source of natural nutrients and pentane-1,5-diol acts as a solvent to unplug the hair follicle as well as acts as an enhancer for uptake of nutrients. Other components are claimed to increase blood flow to the hair papilla. A100 has been effective in earlier studies. The aim of this open explanatory study was to investigate the effect of 4 months twice daily application with this commercial pollen gel, A100, in subjects with male androgenic alopecia. Twenty male subjects, between 18 and 40 years with androgenic alopecia were included. A100 gel was applied to the area of the scalp with poor hair growth twice daily for 4 months. The subjects were seen at the start of treatment and then every month. Sixteen subjects fulfilled the whole 4 months of treatment and 2 fulfilled 3 months of treatment. A statistically significant increase in number of hairs was seen after 4 months of treatment with A100 (p < 0.001). This effect was seen for all types of hair. Fifty-six percent of the 16 subjects who fulfilled the 4 months treatment had an increase in hair growth of more than 50%, and 31% had an increase over 100%. No side effects were seen and the subjects found A100 gel a cosmetically attractive treatment. A100 was in this explanatory study an effective and safe treatment for androgenic alopecia or male pattern baldness.展开更多
文摘The effect of 2-butyne-1, 4-diol on silver electrodeposition process from 5, 5-dimethyl hydantoin solutions was investigated by means of cyclic voltammetric measurement, scanning electron microscopy (SEM) and X-ray diffraction (XRD). Cyclic voltammetric studies indicate that the reduction process of silver electrodeposition is influenced by adding 2-butyne-1, 4-diol. Owing to its adsorption on the electrode surface, 2-butyne-1, 4-diol moderately hinders the mass transfer of the silver complexed ions from the bulk solution to the outer limit of the electrode double layer and affects the electrocrystallization step. Scanning electron microscopy analysis reveals that the presence of 2-butyne-1, 4-diol in the electrolyte is beneficial and the silver deposits obtained are smoother, more compact and more leveled. X-ray diffraction analysis of the silver deposits obtained at 0.5 g·L-1 2-butyne-1, 4-diol indicated that the (110) plane is the most preferred plane and is not affected by the presence of 2-butyne-1, 4-diol in the electrolyte.
文摘目的研究厚朴抗炎有效成分(E)-5-allyl-3'-(prop-1-enyl)biphenyl-2,4'-diol(HK-1)在人、大鼠、比格犬、猴和小鼠的肝微粒体中的代谢稳定性,确定HK-1在大鼠肝微粒体中代谢表型。方法将HK-1在5个种属肝微粒体中孵育,采用UPLC-MS/MS检测方法,通过测定HK-1的剩余浓度,考察它们的代谢稳定性并外推其体内代谢清除率。化学抑制剂法鉴定在大鼠肝微粒体中HK-1的代谢表型。结果 HK-1在人、大鼠、比格犬、猴和小鼠5个种属肝微粒体中半衰期(t_(1/2))分别为9.04、7.36、2.17、4.94、18.09 min;肝微粒体中固有清除率CL_(int)分别为153.40、188.20、639.02、280.60、76.60 m L/(min·mg蛋白);体内固有清除率CL'_(int)分别为151.87、338.76、949.21、416.69、301.61 m L/(min·kg)。在大鼠肝微粒体中HK-1主要被细胞色素CYP2E1、CYP2C、CYP1A2催化代谢。结论HK-1在肝微粒体中由多种酶代谢且代谢很快,其中人肝微粒体和大鼠肝微粒体中半衰期和固有清除率相似,可将大鼠肝微粒体预估人肝微粒体不良反应的风险。
文摘Male pattern baldness or androgenic alopecia is a great problem for many individuals’ especially young people. A100 is composed of two active ingredients, a pollen extract and pentane-1,5-diol. The pollen extract provides a source of natural nutrients and pentane-1,5-diol acts as a solvent to unplug the hair follicle as well as acts as an enhancer for uptake of nutrients. Other components are claimed to increase blood flow to the hair papilla. A100 has been effective in earlier studies. The aim of this open explanatory study was to investigate the effect of 4 months twice daily application with this commercial pollen gel, A100, in subjects with male androgenic alopecia. Twenty male subjects, between 18 and 40 years with androgenic alopecia were included. A100 gel was applied to the area of the scalp with poor hair growth twice daily for 4 months. The subjects were seen at the start of treatment and then every month. Sixteen subjects fulfilled the whole 4 months of treatment and 2 fulfilled 3 months of treatment. A statistically significant increase in number of hairs was seen after 4 months of treatment with A100 (p < 0.001). This effect was seen for all types of hair. Fifty-six percent of the 16 subjects who fulfilled the 4 months treatment had an increase in hair growth of more than 50%, and 31% had an increase over 100%. No side effects were seen and the subjects found A100 gel a cosmetically attractive treatment. A100 was in this explanatory study an effective and safe treatment for androgenic alopecia or male pattern baldness.